1-20 of 32
Carol S. Portlock, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

Anita Kumar, MD, Jason Westin, MD, Stephen J Schuster, MD, Grzegorz S. Nowakowski, MD, Izidore S. Lossos, MD, Connie Lee Batlevi, MDPhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Steven M. Horwitz, MD, Allison P. Jacob, Erel Joffe, MD MSc, Ashlee Joseph, Gottfried R. von Keudell, MD PhD, Leana Laraque, BA, Oscar B Lahoud, MD, Matthew J Matasar, MD, Craig H. Moskowitz, MD, Chelsea D Mullins, BS, Ariela Noy, MD, Colette Owens, MD, Maria Lia Palomba, Carol S. Portlock, MD, Ildefonso Rodriguez-Rivera, MD, Gilles Salles, MDPhD, Venkatraman Seshan, PhD, David J. Straus, MD, Shreya Vemuri, Anas Younes, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138889
Published: 2020
Journal Articles

Expectant Management of Extranodal Marginal Zone Lymphoma of Bronchial-Associated Lymphoid Tissue (BALT)

Yan Leyfman, BS, Erel Joffe, MDMSc, Esther Drill, PhD, Sridevi Rajeeve, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Lia Palomba, Craig H. Moskowitz, Carol S. Portlock, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J Matasar, MD, Anita Kumar, MD, Gottfried R. von Keudell, MD PhD, Connie Lee Batlevi, MD PhD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2826.
https://doi.org/10.1182/blood-2019-123257
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, MD, Ranjana H. Advani, MD, Lihua Budde, MD PhD, Paul M. Barr, MD, Connie L. Batlevi, MD PhD, Philip Caron, MD PhD, Robert W. Chen, MD, Louis S. Constine, MD, Amanda Courtien, Savita Dandapani, MD PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T. Hoppe, MD, Steven M. Horwitz, MD, Matthew J. Matasar, MD, Shoshana T. Miller, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria L. Palomba, MD, Carol S. Portlock, MD, Heiko Schoder, MD, David J. Straus, MD, Joanna C. Yang, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Joachim Yahalom, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 734.
https://doi.org/10.1182/blood.V130.Suppl_1.734.734
Published: 2017
Journal Articles

Active Surveillance for Newly Diagnosed Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Sven Borchmann, Erel Joffe, MDMSc, Craig H. Moskowitz, MD, Andrew D. Zelenetz, MD PhD, Ariela Noy, MD PhD, Carol S Portlock, MD, John F Gerecitano, MD PhD, Connie Batlevi, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Colette N Owens, MD BA, Lia Palomba, MD, Anas Younes, MD, David J. Straus, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 654.
https://doi.org/10.1182/blood.V130.Suppl_1.654.654
Published: 2017
Journal Articles

Impact of PET Staging of Follicular Lymphoma on Treatment Outcomes and Prognosis

Anna Alperovich, MD, Connie L. Batlevi, MD PhD, Andrew M Intlekofer, MD PhD, Craig H. Moskowitz, MD, Steven M. Horwitz, MD, Andrew D. Zelenetz, MD PhD, Maria Lia Palomba, MD, Alison J. Moskowitz, MD, John Gerecitano, MD PhD, Paul A. Hamlin, MD, Matthew J. Matasar, MD, Craig S. Sauter, MD, Anita Kumar, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, Audrey Hamilton, MD, Pamela Drullinsky, MD, Philip Caron, MD PhD, Ai Ni, PhD, Venkatraman Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1494.
https://doi.org/10.1182/blood.V130.Suppl_1.1494.1494
Published: 2017
Journal Articles

Genomic Characteristics Clinical Phenotype and Disease Course of TP53 Mutated Diffuse Large B Cell Lymphoma at Diagnosis and Relapse

Erel Joffe, MDMSc, Connie L. Batlevi, MD PhD, Andrew M Intlekofer, MD PhD, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz, MD, Maria L. Palomba, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, John Gerecitano, MD PhD, Steven M. Horwitz, MD, Alison J. Moskowitz, MD, Paul A. Hamlin, MD, Matthew J. Matasar, MD, Anita Kumar, MD, Jie He, PhD, Vincent A Miller, MD, Franck Rapaport, PhD, Elli Papaemmanuil, PhD, Ahmet Dogan, MD PhD, Anas Younes, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1460.
https://doi.org/10.1182/blood.V130.Suppl_1.1460.1460
Published: 2017
Journal Articles

Outcome of Initial Observation in Mantle Cell Lymphoma

Anita Kumar, MD, Zhitao Ying, MD, Anna Alperovich, MD, Ahmet Dogan, Paul A Hamlin, Jr., MD, Craig H. Moskowitz, MD, Carol S Portlock, MD, Andrew D. Zelenetz, Zhigang Zhang, PhD, Kaitlin M Woo, MS, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 1803.
https://doi.org/10.1182/blood.V128.22.1803.1803
Published: 2016
Journal Articles

Intervention Versus Observation: What Is the Appropriate Endpoint? Assessment of Endpoints in Patients with Advanced Stage Follicular Lymphoma Who Are Initially Observed

Jacob D Soumerai, MD, Kurt S Bantilan, MPH, Ai Ni, PhD, Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Amanda R Copeland, RN, MSN, CNS, Matthew J. Matasar, MD MS, David J Straus, MD, John F Gerecitano, MD PhD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Carol S Portlock, MD, Maria Lia Palomba, MD, Craig H Moskowitz, MD, Alison J Moskowitz, MD, Ariela Noy, MD PhD, Craig S Sauter, MD, Anita Kumar, MD, Andrew M Intlekofer, MD PhD, Philip Caron, MD PhD, Pamela Drullinsky, MD, Anas Younes, MD, Andrew D Zelenetz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1777.
https://doi.org/10.1182/blood.V128.22.1777.1777
Published: 2016
Journal Articles

Incidence of Infectious Complications Associated with Bendamustine and Anti-CD20 Monoclonal Antibody Combination at Memorial Sloan Kettering Cancer Center (MSKCC)

Thu Oanh Dang, PharmD,BCOP, Ai Ni, PhD, John F Gerecitano, MD PhD, Paul A Hamlin, Jr., MD, Tobias M Hohl, MD PhD, Anita Kumar, MD, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD PhD, Lia Palomba, MD, Carol S Portlock, MD, Matthew J. Matasar, MD MS, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, David J Straus, MD
Journal: Blood
Blood (2016) 128 (22): 1778.
https://doi.org/10.1182/blood.V128.22.1778.1778
Published: 2016
Journal Articles

Benchmark of Progression Free Survival for Multiple Lines of Therapy in Follicular Lymphoma Treated in the Rituximab Era

Anna Alperovich, MD, Connie Batlevi, MD PhD, Katy Smith, MBBS, MRCP, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MDMSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 2955.
https://doi.org/10.1182/blood.V128.22.2955.2955
Published: 2016
Journal Articles

Outcomes of Follicular Lymphoma Patients By Dynamic FLIPI at Diagnosis and Initial Treatment in the Post-Rituximab Era

Connie Batlevi, MD PhD, Anna Alperovich, MD, Katy Smith, MBChB BSc, Zhitao Ying, MD, Jacob D Soumerai, MD, Amanda R Copeland, RN, MSN, CNS, Erel Joffe, MD MSc, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A Hamlin, Jr., MD, Steven M Horwitz, MD, Andrew M Intlekofer, MD PhD, Anita Kumar, MD, Matthew J. Matasar, MD MS, Alison J. Moskowitz, MD, Craig H Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S Portlock, MD, Craig S Sauter, MD, David J Straus, MD, Andrew D. Zelenetz, MD PhD, Ai Ni, PhD, Venkatraman E Seshan, PhD, Anas Younes, MD
Journal: Blood
Blood (2016) 128 (22): 4119.
https://doi.org/10.1182/blood.V128.22.4119.4119
Published: 2016
Journal Articles

A Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/ Refractory Hodgkin Lymphoma

Miguel-Angel Perales, MD, Christina Cho, MD, Anne Eaton, MS, Alison J Moskowitz, MD, Victoria Nguyen, BS, Anne Marie R. Gonzales-Dadiz, BS, Sean Devlin, PhD, Sergio A. Giralt, MD, Ann A. Jakubowski, MD PhD, Matthew J. Matasar, MD MS, Ariela Noy, MD, Carol S. Portlock, MD, David J. Straus, MD, James W. Young, MD, Juliet N. Barker, MBBS(Hons), FRACP, Craig H. Moskowitz, MD
Journal: Blood
Blood (2015) 126 (23): 4383.
https://doi.org/10.1182/blood.V126.23.4383.4383
Published: 2015
Journal Articles

Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma

Jacob D Soumerai, MD, Andrew D Zelenetz, MD PhD, Craig H Moskowitz, MD, Anas Younes, MD, Maria Lia Palomba, MD, Paul A Hamlin, Jr., MD, Ariela Noy, MD, Steven M Horwitz, MD, Matthew J. Matasar, MD MS, Alison J Moskowitz, MD, Carol S Portlock, MD, David J Straus, MD, Alice Chen, MD, Richard F Little, MDMPH, Fallon France, Juho Whang, Nishant Mishra, Christine Jarjies, John F Gerecitano, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2691.
https://doi.org/10.1182/blood.V126.23.2691.2691
Published: 2015
Journal Articles

Defining the Incidence and Clinical Impact of Genomic Alterations Across Different Histologic Types of Lymphoma Using a Clinically Validated Comprehensive Targeted Sequencing Assay

Connie Batlevi, MD PhD, Franck Rapaport, PhD, Andrew M. Intlekofer, MD PhD, Anne Reiner, MPH, Craig H Moskowitz, MD, Steven M Horwitz, MD, Andrew D Zelenetz, MD PhD, Lia Palomba, MD, Alison J Moskowitz, MD, John F. Gerecitano, MD, Paul A Hamlin, Jr., MD, Amanda R. Copeland, RN, MSN, CNS, Matthew J Matasar, MD MS, Craig S. Sauter, MD, Anita Kumar, MD, Ariela Noy, MD, David J. Straus, MD, Carol S. Portlock, MD, Frederick Criscuolo, PhD, Jie He, PhD, Daniel Royston, MD, Sohail Balasubramanian, MS, Yekaterina Reznikovskaya, BA, Janine D. Pichardo, BS, Phil Stephens, PhD, Vincent Miller, MD, Ross L. Levine, MD, Venkatraman Seshan, PhD, Ahmet Dogan, MD PhD, Anas Younes, MD
Journal: Blood
Blood (2015) 126 (23): 2668.
https://doi.org/10.1182/blood.V126.23.2668.2668
Published: 2015
Journal Articles

Dose-Adjusted EPOCH +/- Rituximab in Older Patients with High Grade Diffuse Large B-Cell Lymphoma, Burkitt and T-Cell Lymphoma: An Effective Regimen with Acceptable Toxicity Profile

Colette N Owens, MD BA, Jocelyn C Migliacci, B.S., Steven M. Horwitz, MD, Matthew J Matasar, MD MS, Alison J Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S. Portlock, MD, David J. Straus, MD, Anas Younes, Andrew D. Zelenetz, MD PhD, Paul A. Hamlin, MD
Journal: Blood
Blood (2014) 124 (21): 4450.
https://doi.org/10.1182/blood.V124.21.4450.4450
Published: 2014
Journal Articles

Greater Total Dose and Duration of Treatment with Bortezomib Are Associated with Higher Incidence of Chalazion and Other Ocular Side Effects

Karuna Ganesh, MBBChir, PhD, Connie Batlevi, MD PhD, Zhigang Zhang, PhD, Hani Hassoun, MD, Nikoletta Lendvai, MD PhD, Heather Landau, MD, Craig H. Moskowitz, MD, Philip Caron, MD PhD, Robert Motzer, MD, Sergio A Giralt, MD, Paul Hamlin, MD, Stuart M. Lichtman, MD, Matthew J. Matasar, MD MS, Carol S Portlock, MD, Neerav Shukla, MD, Carol Wasserheit-Lieblich, MD, Andrew D. Zelenetz, MD PhD, John F. Gerecitano, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3487.
https://doi.org/10.1182/blood.V124.21.3487.3487
Published: 2014
Journal Articles

Safety and Early Efficacy in an Ongoing Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 30 Gray Involved-Site Radiotherapy for Newly Diagnosed, Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Joachim Yahalom, MD, Heiko Schoder, MD, Philip Caron, MD PhD, Pamela Drullinsky, MD, John F. Gerecitano, MD PhD, Audrey Hamilton, MD, Paul Hamlin, MD, Steven M. Horwitz, MD, Alexandra G. Jacob, BS, Matthew J. Matasar, MD MS, Susan McCall, Alison J Moskowitz, MD, Ariela Noy, Lia Palomba, MD, Carol S Portlock, MD, David J. Straus, MD, Stephanie Verwys, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Anas Younes, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2014) 124 (21): 3085.
https://doi.org/10.1182/blood.V124.21.3085.3085
Published: 2014
Journal Articles

Identification of Actionable Genomic Alterations Across Different Lymphoma Histologies Using a Comprehensive Next Generation Genomic Sequencing Clinical Assay

Connie Batlevi, MD PhD, Craig H. Moskowitz, MD, Andrew D. Zelenetz, MD PhD, Steven M. Horwitz, MD, Lia Palomba, MD, John F. Gerecitano, MD PhD, Amanda R. M. Copeland, MSN, Paul Hamlin, MD, Matthew J. Matasar, MD MS, Craig S. Sauter, MD, Alison J Moskowitz, MD, Ariela Noy, David J. Straus, MD, Carol S Portlock, MD, Colleen Mazzei, BS, Janine D. Pichardo, BS, Vincent Miller, MD, Phil J Stephens, PhD, Jie He, PhD, Julie T Feldstein, MD, Ross L. Levine, MD, Ahmet Dogan, MD PhD, Anas Younes, MD
Journal: Blood
Blood (2014) 124 (21): 3000.
https://doi.org/10.1182/blood.V124.21.3000.3000
Published: 2014
Journal Articles

Safety and Early Efficacy Analysis of a Novel Combination of the PARP Inhibitor Veliparib (ABT-888) Plus Bendamustine and Rituximab in Patients with Lymphoma

John F. Gerecitano, MD PhD, Paul Hamlin, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD MS, Alison J. Moskowitz, MD, Craig H. Moskowitz, MD, Ariela Noy, MD, Carol S Portlock, MD, Maria Lia Palomba, MD, David J. Straus, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Alice Chen, MD, Richard F Little, MPH, MD, France Fallon, Juho Whang
Journal: Blood
Blood (2014) 124 (21): 1739.
https://doi.org/10.1182/blood.V124.21.1739.1739
Published: 2014
Journal Articles

FDG-PET Adapted Sequential Therapy With Brentuximab Vedotin and Augmented ICE Followed By Autologous Stem Cell Transplant For Relapsed and Refractory Hodgkin Lymphoma

Alison Moskowitz, MD, Heiko Schoder, MD, John F. Gerecitano, MD, PhD, Paul Hamlin, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, MS, Vahakn S Keskinyan, Susan McCall, Ariela Noy, MD, M. Lia Palomba, MD, Carol S. Portlock, MD, David J Straus, MD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D Zelenetz, MD, PhD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2013) 122 (21): 2099.
https://doi.org/10.1182/blood.V122.21.2099.2099
Published: 2013